Safety of rofecoxib in nonsteroidal anti-inflammatory drugs intolerance

被引：6
作者：
Muñoz-Bellido, FJ [1 ]
Terrón, M [1 ]
León, A [1 ]
机构：
[1] Hosp Martinez Anido, Unidad Alergia, Salamanca 37192, Spain
来源：
ALLERGY | 2003年 / 58卷 / 10期
关键词：
anaphylactoid reaction; angioedema; asthma; cyclooxygenase-2; nonsteroidal anti-inflammatory drugs; nonsteroidal anti-inflammatory drugs intolerance; rofecoxib; urticaria;
D O I：
10.1034/j.1398-9995.2003.00166.x
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1072 / 1075
页数：4
相关论文
共 22 条
[1]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[2]   Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions [J].
Borges, MS ;
Capriles-Hulett, A ;
Caballero-Fonseca, F ;
Pérez, CR .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (03) :201-204
[3]   Celecoxib in patients with asthma and aspirin intolerance. [J].
Dahlen, B ;
Szczeklik, A ;
Murray, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :142-142
[4]   Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2. [J].
FitzGerald, GA ;
Patrono, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :433-442
[5]  
Fleming M, 2001, JAMA-J AM MED ASSOC, V286, P2808
[6]   Celecoxib, safe in NSAID intolerance [J].
García-Rodríguez, RM ;
Hinojosa, M ;
Camach-Garrido, E ;
Gimeno, PB ;
García, CM .
ALLERGY, 2002, 57 (11) :1085-1086
[7]   Rofecoxib as an alternative in aspirin hypersensitivity [J].
Hinrichs, R ;
Ritzkowsky, A ;
Hunzelmann, N ;
Krieg, T ;
Scharffetter-Kochanek, K .
ALLERGY, 2001, 56 (08) :789-789
[8]   Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides [J].
Kaur, C ;
Sarkar, R ;
Kanwar, AJ .
DERMATOLOGY, 2001, 203 (04) :351-351
[9]   Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib [J].
Konstam, MA ;
Weir, MR ;
Reicin, A ;
Shapiro, D ;
Sperling, RS ;
Barr, E ;
Gertz, BJ .
CIRCULATION, 2001, 104 (19) :2280-2288
[10]  
MUKHERJEE D, 2001, JAMA-J AM MED ASSOC, V286, P2809
123